


Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft









 







Insights | PGIM


















Insights
www.pgim.com


en


fx4XrflzvoEYaRXEwLm8Ror

Asset Management

Skip to main content














 News


 Careers


 Contact












Menu



Close






PGIM Home







 Home


 About Us


 Overview


 Partnering with PGIM


 Leadership


 Strengths


 Company Values


 History


 Locations




 Our Businesses


 Overview


 PGIM Fixed Income


 PGIM Real Estate


 Jennison Associates


 QMA


 Pricoa Capital Group


 PGIM Real Estate Finance


 International Investments


 PGIM Funds




Insights
 Insights


 Overview


 Megatrends


 Current Views


 Asset Class Insights








Close












{}






Z7_K8HEHHG0LOCHF0ABFJMQE5RDN4







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 
































EMERGING MARKETS AT THE CROSSROADS


A radical shift in the forces shaping emerging market growth will require investors to take a different investment approach from what may have worked in the past.

 Read more about the new emerging markets landscapeRead more about the new emerging markets landscape














 


For latest news and content, 
			follow @PGIM on Twitter.





 













Z7_K8HEHHG0LOCHF0ABFJMQE5RTP5







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 




































Megatrends
Long-term views on the investment implications of megatrends.
 Learn more about megatrends
























Current Views
Views addressing today’s institutional investor concerns.
 Read our current views
























Asset Class Insights
Expert insights from our asset class specialists.
 View insights by asset class























 

Z7_K8HEHHG0L0N540ABFSHGHT3V70







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 




































MEGATRENDS
We see alpha in today’s global megatrends. At PGIM, we help clients see the investable implications of today’s most important economic and societal trends – the megatrends that we believe will reshape the U.S. and the world, driving long-term value. PGIM provides a broader lens through which to view those opportunities, across a broad range of asset classes and countries, to capture real investment alpha. Unprecedented urban expansion and global longevity are two of those trends.






























Urban Expansion






























Rising Longevity























 

Z7_K8HEHHG0LOCHF0ABFJMQE5RNT1







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 

























					
					
						CURRENT VIEWS
					
				




 


























Value of Active
Read more about the value of active management






























Markets & Economy
Read our commentary on the markets & economy






























Asset Allocation
Read our insights on asset allocation strategies























 

Z7_K8HEHHG0LOCHF0ABFJMQE5R775







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 






































ASSET CLASS INSIGHTS
PGIM’s independent investment businesses specialize by asset class and approach. Read institutional thought leadership by strategy, from capital market experts.



















































 



 





Back to top



















 

HBM Healthcare Investments - Home

























 






ende 

Contact


 
 





COMPANYPORTFOLIOINVESTORS




Search




















 
 
 






Welcome

HBM Healthcare Investments invests in the drugs and healthcare technologies of tomorrow.

 





 



Welcome

HBM Healthcare Investments invests in the drugs and healthcare technologies of tomorrow.

 

 






Investment

HBM Healthcare Investments is an attractive alternative to investments in large pharmaceutical and biotech corporations.

 





 



Investment

HBM Healthcare Investments is an attractive alternative to investments in large pharmaceutical and biotech corporations.

 

 






Progress

HBM Healthcare Investments enables the development of promising new biotechnologies.

 





 



Progress

HBM Healthcare Investments enables the development of promising new biotechnologies.

 

 






Success

Profit of CHF 136.8 million for 2016/2017 financial year and increased NAV per share by 15.2 percent. Board of Directors proposing increase in the cash dividend of 30 centimes, to CHF 5.80 per share 

 





 



Success

Profit of CHF 136.8 million for 2016/2017 financial year and increased NAV per share by 15.2 percent. Board of Directors proposing increase in the cash dividend of 30 centimes, to CHF 5.80 per share 

 

 






Share price

Current share price and price development.

 





 



Share price

Current share price and price development.

 

 

 


 











 


 



© HBM Healthcare Investments AG




 














HBM Healthcare Investments - Press Releases

























 






ende 

Contact


 
 





COMPANYPORTFOLIOINVESTORS




Search














Share PriceNet Asset Value (NAV)Financial ReportsMedia ReleasesArchivePresentationsAnalyst's ReportsInvestment GuidelinesCash DistributionsShare Buy-back ProgrammeBond IssueInvestor InformationManagement TransactionsNMPI StatusCalendarFAQNews Service 







Media Releases 2017




NAV Key Figures as at 30 June 2017 (66 KB)



Shareholders’ Meeting approved all proposals by the Board of Directors (49 KB)
26.6.2017



Invitation to the 16th ordinary Shareholders' meeting  (55 KB)
2.6.2017



Publication of Annual Report 2016/2017 and Invitation to the Ordinary Shareholders' Meeting (49 KB)
2.6.2017



Bioverativ acquires HBM-portfolio company True North Therapeutics for up to USD 825 million plus assumed cash (50 KB)
23.5.2017



HBM Healthcare Investments generated a profit of CHF 136.8 million for the 2016/2017 financial year and increased net asset value per share by 15.2 percent. Board of Directors proposing an increase in the cash dividend of 30 centimes, to CHF 5.80 per share (134 KB)
16.5.2017



HBM Healthcare Investments commits EUR 20 million in growth capital to Switzerland based Amicus SA (47 KB)
27.4.2017



HBM Healthcare Investments expects to report a net profit of around CHF 136 million for the financial year 2016/2017 – increase of the net asset value per share of around 15 percent (47 KB)
3.4.2017



HBM Healthcare Investments Quarterly Report 2016 (53 KB)
31.1.2017



Two IPOs from the HBM Healthcare Investments portfolio increase net asset value per HBM-share by CHF 2.30 (48 KB)
27.1.2017



Net Asset Value per HBM-share of CHF 133.43 as at  31 December 2016 (49 KB)
3.1.2017





 








News


Shareholders’ Meeting approved all proposals by the Board of Directors


Invitation to the 16th ordinary Shareholders' meeting 


Publication of Annual Report 2016/2017 and Invitation to the Ordinary Shareholders' Meeting


more






Financial Reports


 

more


Company Presentation


more






Share Price


 
SIX Swiss Exchange TickerHBMN 

Key Figures









                            as at 15 July 2017                          

                            CHF                          



                            NAV per share                          

                            141.64                          



                            Net assets                          

                            Mio. 996                          












 


 



© HBM Healthcare Investments AG


CreditsImportant legal information



 












HBM Healthcare Investments - Contact

























 






ende 

Contact


 
 





COMPANYPORTFOLIOINVESTORS




Search





















Contact


HBM Healthcare Investments Ltd

Bundesplatz 1P.O. Box 1145CH-6301 ZugSwitzerlandPhone: +41 41 710 75 77 Fax: +41 41 710 75 78 

Contact Form


 
Title* 
Mrs
Mr

First name* Last name* Company 
 
Address* 
 
ZIP Code* / City* Country* 
 
Email* 
 
Phone 
 
  
I would like to receive the investor's documentation package

  
I would like to be contacted by an investment advisor

Message* 



Security query* 


  
Please enter the characters you see on the screen into the box.

 
reset
submit 
 
 
* mandatory

 








News


Shareholders’ Meeting approved all proposals by the Board of Directors


Invitation to the 16th ordinary Shareholders' meeting 


Publication of Annual Report 2016/2017 and Invitation to the Ordinary Shareholders' Meeting


more






Financial Reports


 

more


Company Presentation


more






Share Price


 
SIX Swiss Exchange TickerHBMN 

Key Figures









                            as at 15 July 2017                          

                            CHF                          



                            NAV per share                          

                            141.64                          



                            Net assets                          

                            Mio. 996                          












 


 



© HBM Healthcare Investments AG


CreditsImportant legal information



 












HBM Healthcare Investments - Welcome to HBM Healthcare Investments

























 






ende 

Contact


 
 





COMPANYPORTFOLIOINVESTORS




Search














ProfileInvestment GuidelinesOrganisationCorporate GovernanceArticles of Association 







 

Welcome to HBM Healthcare Investments

HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).

 








News


Shareholders’ Meeting approved all proposals by the Board of Directors


Invitation to the 16th ordinary Shareholders' meeting 


Publication of Annual Report 2016/2017 and Invitation to the Ordinary Shareholders' Meeting


more






Financial Reports


 

more


Company Presentation


more






Share Price


 
SIX Swiss Exchange TickerHBMN 

Key Figures









                            as at 15 July 2017                          

                            CHF                          



                            NAV per share                          

                            141.64                          



                            Net assets                          

                            Mio. 996                          












 


 



© HBM Healthcare Investments AG


CreditsImportant legal information



 












HBM Healthcare Investments - Portfolio overview

























 






ende 

Contact


 
 





COMPANYPORTFOLIOINVESTORS




Search














OverviewLargest InvestmentsPortfolio News 







 

Portfolio overview as at 30 June 2017


Allocation of assets














in % of total assets




Private companies


14




Funds


14




Public companies mainly originating from the private portfolio


65




Other assets


3




Cash and cash equivalents


4




 

Currency allocation









Assets held in


in % of total assets




USD                                                                                             


67




EUR


11




CHF


4




Others (SEK, GBP, INR, DKK)


18





 








News


Shareholders’ Meeting approved all proposals by the Board of Directors


Invitation to the 16th ordinary Shareholders' meeting 


Publication of Annual Report 2016/2017 and Invitation to the Ordinary Shareholders' Meeting


more






Financial Reports


 

more


Company Presentation


more






Share Price


 
SIX Swiss Exchange TickerHBMN 

Key Figures









                            as at 15 July 2017                          

                            CHF                          



                            NAV per share                          

                            141.64                          



                            Net assets                          

                            Mio. 996                          












 


 



© HBM Healthcare Investments AG


CreditsImportant legal information



 












HBM Healthcare Investments - Board of Directors and Management of HBM BioVentures (Cayman) Ltd

























 






ende 

Contact


 
 





COMPANYPORTFOLIOINVESTORS




Search














ProfileInvestment GuidelinesOrganisationBoard of DirectorsManagementCayman SubsidiaryInvestment AdvisorCorporate GovernanceArticles of Association 







HBM Healthcare Investments (Cayman) Ltd

HBM Healthcare Ltd’s investment activities are handled by its subsidiary HBM Healthcare Investments (Cayman) Ltd.

Board of Directors and Management

 




Jean-Marc LeSieur

Managing Director




Richard H. Coles

Member of the Board of Directors




Sophia A. Harris

Member of the Board of Directors





Dr Andreas Wicki

Member of the Board of Directors




Richard Paul Woodhouse

Member of the Board of Directors








Contact

HBM Healthcare Investments (Cayman) Ltd.
Governors Square, Suite #4-212-2 23 Lime Tree Bay AvenueWest BayGrand Cayman, Cayman Islands








                            Phone                          

                            +1 345 946 8002                          



                            Fax                          

                            +1 345 946 8003                          



 
Jean-Marc LeSieur, lesieur@hbmcayman.com




 








News


Shareholders’ Meeting approved all proposals by the Board of Directors


Invitation to the 16th ordinary Shareholders' meeting 


Publication of Annual Report 2016/2017 and Invitation to the Ordinary Shareholders' Meeting


more






Financial Reports


 

more


Company Presentation


more






Share Price


 
SIX Swiss Exchange TickerHBMN 

Key Figures









                            as at 15 July 2017                          

                            CHF                          



                            NAV per share                          

                            141.64                          



                            Net assets                          

                            Mio. 996                          












 


 



© HBM Healthcare Investments AG


CreditsImportant legal information



 












HBM Healthcare Investments - Board of Directors and Management of HBM BioVentures (Cayman) Ltd

























 






ende 

Contact


 
 





COMPANYPORTFOLIOINVESTORS




Search














ProfileInvestment GuidelinesOrganisationBoard of DirectorsManagementCayman SubsidiaryInvestment AdvisorCorporate GovernanceArticles of Association 







HBM Healthcare Investments (Cayman) Ltd

HBM Healthcare Ltd’s investment activities are handled by its subsidiary HBM Healthcare Investments (Cayman) Ltd.

Board of Directors and Management

 




Jean-Marc LeSieur

Managing Director




Richard H. Coles

Member of the Board of Directors




Sophia A. Harris

Member of the Board of Directors





Dr Andreas Wicki

Member of the Board of Directors




Richard Paul Woodhouse

Member of the Board of Directors








Contact

HBM Healthcare Investments (Cayman) Ltd.
Governors Square, Suite #4-212-2 23 Lime Tree Bay AvenueWest BayGrand Cayman, Cayman Islands








                            Phone                          

                            +1 345 946 8002                          



                            Fax                          

                            +1 345 946 8003                          



 
Jean-Marc LeSieur, lesieur@hbmcayman.com




 








News


Shareholders’ Meeting approved all proposals by the Board of Directors


Invitation to the 16th ordinary Shareholders' meeting 


Publication of Annual Report 2016/2017 and Invitation to the Ordinary Shareholders' Meeting


more






Financial Reports


 

more


Company Presentation


more






Share Price


 
SIX Swiss Exchange TickerHBMN 

Key Figures









                            as at 15 July 2017                          

                            CHF                          



                            NAV per share                          

                            141.64                          



                            Net assets                          

                            Mio. 996                          












 


 



© HBM Healthcare Investments AG


CreditsImportant legal information



 















HBM Healthcare Investments (Cayman) Ltd. - Relationship Science



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





HBM Healthcare Investments (Cayman) Ltd.



Overview
In The News Board of Directors Paths



HBM Healthcare Investments (Cayman) Ltd.



 OVERVIEW



Headquarters


Governors Square, 23 Lime Tree Bay Avenue, Suite 4-212-2, George Town, West Bay




Industries


Hospitals & Patient Services 




Company Description


HBM Healthcare Investments (Cayman) Ltd., part of HBM Partners AG, is a company headquartered in George Town, Cayman Islands, that provides healthcare services.






 In The News
          See more




GlobeNewswire
July 20, 2017





                        Amphora Medical Closes $35.5 Million Series B Financing                    





Marketwired
June 25, 2015





                        Autonomic Technologies Completes Transatlantic Series D Financing of $43.2M:                    





Marketwired
January 8, 2015





                        Vascular Dynamics Inc. Secures $16.85 Million Series B Financing: The Funding Will Be Used to Advance the Company's Program for the Treatment of Resistant Hypertension                    





VCCircle.com
October 24, 2014





                        FIPB nixes HBM Partners deal to buy stake in Amanta Healthcare from IFCI VC                    





PR Newswire
March 26, 2014





                        Kolltan Pharmaceuticals Obtains $60 Million in Series D Financing                    







See full news coverage and complete stories with RelSci Professional.

Create Your News Feed








See  More 






                          Board of Directors                        



Andreas Wicki

Chief Executive Officer at HBM Healthcare Investments AG




Thomas Thaler

Investment Advisor at HBM Partners AG (Investment Management)







See our list of current and previous board members when you upgrade.

Start My Free Trial ➤








See  More 


 


 Paths to HBM Healthcare Investments (Cayman) Ltd.



                        HBM Healthcare Investments (Cayman) Ltd.                    




 You



 Connections via Relationship Science



 HBM Healthcare Investments (Cayman) Ltd.






Sync your contacts to see how you can connect with HBM Healthcare Investments (Cayman) Ltd..

Start My Free Trial ➤








See  More 


 



You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.















Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤















HBM Healthcare Investments - HBM Partners Ltd


























 






ende 

Contact


 
 





COMPANYPORTFOLIOINVESTORS




Search














ProfileInvestment GuidelinesOrganisationBoard of DirectorsManagementCayman SubsidiaryInvestment AdvisorCorporate GovernanceArticles of Association 







HBM Partners Ltd

HBM Partners Ltd, based in Zug, Switzerland, provides defined advisory services as investment advisor for HBM Healthcare Investments (Cayman) Ltd. HBM Partners Ltd is particularly active in identifying and evaluating possible investment targets, in monitoring existing investments and in evaluating and assessing potential exit strategies.

Board of Directors, Management and Team

 




Stanislas Poniatowski

Chairman of the Board of Directors




Dr Dr h.c. Henri B. Meier

Member of the Board of Directors




Didier de Montmollin

Member of the Board of Directors




Dr Andreas Wicki

Management, CEO




Erwin Troxler

Management, CFO




Dr Ulrich Geilinger

Management, Head Private Equity




Dr Alexander Asam, MBA

Investment Advisor




Dr Priyanka Belawat

Investment Advisor




Axel Bolte, MBA

Investment Advisor





Dr Emil Bujak

Investment Advisor





Dr Matthias Fehr, CFA

Investment Advisor




Nina Good

Compliance




Thomas Heimann

Risk Management




Dr Dominique Küttel, CFA

Business Development & Distribution




Dr Chandra Leo, MBA

Investment Advisor




Dr Ivo Staijen, CFA

Investment Advisor, Head Public Equity




Dr Thomas Thaler

Investment Advisor








Contact

HBM Partners AG
Bundesplatz 1P.O. Box 11456300 ZugSchweiz








                            Phone                          

                            +41 43 888 71 71                          



                            Fax                          

                            +41 43 888 71 72                          



 
Contact us



 

How you will find us:




HBM Partners AGBundesplatz 16301 ZugSuisseroute planner




 








News


Shareholders’ Meeting approved all proposals by the Board of Directors


Invitation to the 16th ordinary Shareholders' meeting 


Publication of Annual Report 2016/2017 and Invitation to the Ordinary Shareholders' Meeting


more






Financial Reports


 

more


Company Presentation


more






Share Price


 
SIX Swiss Exchange TickerHBMN 

Key Figures









                            as at 15 July 2017                          

                            CHF                          



                            NAV per share                          

                            141.64                          



                            Net assets                          

                            Mio. 996                          












 


 



© HBM Healthcare Investments AG


CreditsImportant legal information



 





















 





HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD. Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
                    

•   GRAND CAYMAN, E9
                          • Investment Advisor
                      
How do I update this listing?




                                             HBM Healthcare Investments (cayman) Ltd. is based out of Grand Cayman. HBM Healthcare Investments (cayman) Ltd. is a registered investment advisory firm  with  0 clients and discretionary assets under management (AUM) of $0 (Form ADV from 2002-01-23).    WhaleWisdom has at least 40 13D/G filings and 4 insider transactions (Form 3,4,5) in our database for HBM Healthcare Investments (cayman) Ltd.. 
                                           














Summary
Inv. Advisor Info
13D/G
Insider (Form 4)
UK Holdings



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




hbm healthcare investments (cayman) ltd.


2454 WEST BAY ROAD, 3RD FLOOR

GRAND CAYMAN
E9
                                                        
                                                    00000


              Business Phone:
              1 345 946 8002
SEC SIC CODE:2834-PHARMACEUTICAL PREPARATIONS







Recent SEC Filings




4 filed on 07/21/2017
4 filed on 07/18/2017
4 filed on 07/13/2017
4 filed on 07/07/2017
4 filed on 07/05/2017
4 filed on 06/29/2017
4 filed on 06/05/2017
4 filed on 04/28/2017
4 filed on 04/25/2017
4 filed on 04/20/2017











Current 13D/G Holdings


Stock
Sector
Shares Held
Market Value
Rank
Source
Source Date





Advanced Accelerator Applications SA ADR (AAAP)


      HEALTH CARE
    

      3,435,645
    

      91,937,860.20
    

      1
    

      13G
    

      2016-12-31
    



Icagen (ICGN)


      HEALTH CARE
    

      1,200,000
    

      61,920,000.00
    

      2
    

      13G
    

      2005-12-31
    



Micrus Endovascular Corp (MEND)


      HEALTH CARE
    

      1,985,739
    

      23,054,429.79
    

      3
    

      13G
    

      2008-12-31
    



EIGER BIOPHARMACEUTICALS INC COM STK (EIGR)


      HEALTH CARE
    

      603,830
    

      7,022,542.90
    

      4
    

      13G
    

      2016-12-31
    



Alimera Sciences Inc. (ALIM)


      HEALTH CARE
    

      3,250,011
    

      3,510,011.88
    

      5
    

      13G
    

      2016-12-31
    



Nabriva Therapeutics AG (NBRV)


      HEALTH CARE
    

      276,000
    

      2,978,040.00
    

      6
    

      13G
    

      2015-09-23
    



Unknown (unknown)




      4,110,349
    



      7
    

      13G
    

      2014-09-26
    



ObsEva SA (OBSV)


      HEALTH CARE
    

      2,413,275
    



      8
    

      13G
    

      2017-01-25
    










View Last Form Adv Compilation Report on Record

HBM, LLC
 
33 EAST MAIN STREET, SUITE 400


MADISON
WI
            
        53703
Country: United States


          Business Phone:
          608-257-0945
Fax:
              608-257-5764


Professional Investment Advisor Data

SEC Registration as :




Form of Organization:
Limited Liability Company 


Organized in:
WI


Number of employees:
0


Other Business Activities:
lawyer or law firm


Advisor Fees/Compensation:
Percentage of assets under management



        Amount of client funds and securities:
      




            Total Number of Clients:
          




            Amount of client funds and securities by related persons:
          




                Total Number of clients from related persons:
              



Disclosures:




    Data above was derived from SEC filings.
  



Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...




**EXPERIMENTAL** Current UK Positions
Updated daily

    Contains transactions from January 1st, 2015 on.
  



Holder
Issuer
Transaction Date
Number of Voting Rights
% of Voting Rights




HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
Vectura Group PLC
2017-04-06
67,818,316
9.999%


HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
SKYEPHARMA
2015-03-09
29,641,522
28.28%



Position History



Holder
Issuer
Transaction Date
Number of Voting Rights
% of Voting Rights




HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
Vectura Group PLC
2017-01-16
67,698,836
9.986%


HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
Vectura Group PLC
2016-06-10
70,274,572
10.46%


HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
Vectura Group PLC
2016-06-10
70,274,572
10.46%


HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
SKYEPHARMA
2015-02-24
28,338,452
27.037%


HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
SKYEPHARMA
2015-02-06
27,406,531
26.148%


HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
SKYEPHARMA
2015-01-27
26,561,205
25.342%











Elevate your investments
Try it for free




















HBM Healthcare Investments (Cayman) Ltd. - [LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal 















Zum Inhalt




Home
About us
Contact
















 News
 People
 Products
 Deals
 Organisations


» Follow us on twitter!
» Get Free Newsletter!


Top News

Emergent BioSolutions Acquires ACAM2000 Business from Sanofi
Ali Mortazavi Appointed as Board Chairman of Ultromics Ltd
TATAA Biocenter & BTU: Two-tailed PCR for microRNA Analysis
G1 Therapeutics Appoints  Andrew Witty to Board of Directors
FDA Advisory Committee Recommends Novartis� CAR-T Therapy
» More News!
» Submit your News!


 

Upcoming Events

Berlin Conference on Life Sciences 2018
Citi�s 12th Annual Biotech Conference 2017 Boston
Basel Life 2017 (EMBO � MipTec)
MSACL 2017 EU Salzburg
Morgan Stanley Global Healthcare Conference 2017 New York
BoAML Global Healthcare Conference 2017 London
HUPO 2017 Dublin (16th Annual World Congress)
SMASH 2017 NMR Conference Baveno, Italy
European Biotech Week 2017
BioPharm America 2017 Boston
Sachs Annual Biotech in Europe Forum 2017 Basel
Asebio Investor Day 2017 Barcelona
European Business Development Conference 2017 Heidelberg (EBDC 2017)
WorldLab 2017 Durban
CPhI Worldwide 2017 Frankfurt
» More Events!
» Submit your Event!


 

Bio Regions & Life Sciences Clusters

BIOPRO Baden-W�rttemberg GmbH
FlandersBio vzw
ScanBalt Network (Scanbalt fmba)
Biosaxony e. V.
Germany Trade and Invest � Gesellschaft f�r Au�enwirtschaft und Standortmarketing mbH
Medicon Valley Alliance (MVA)
Life Science Austria (LISA), Service Unit of Austria Wirtschaftsservice GmbH
One Nucleus
MediWales
Ci3 Cluster (Cluster f�r Individualisierte ImmunIntervention e. V.)
» More Clusters and Regions!
» Submit your Cluster or Region!


 

Business Parks & Science Centres

IZB Innovations- und Gr�nderzentrum Biotechnologie Martinsried (F�rdergesellschaft IZB mbH)
Genopole (GIP Genopole)
Technologiepark Heidelberg GmbH
Parc Cientific de Barcelona (BCP, Barcelona Science Park Foundation)
Campus Vienna Biocenter Association (VBC)
Medeon Science Park
Oxford Science Park, The
Leiden Bio Science Park Foundation
BioCity Nottingham Ltd.
London BioScience Innovation Centre (LBIC)
» More Business Parks!
» Submit your Business Park!


 

Associations

EuropaBio � the European Association of Bioindustries
BioIndustry Association (BIA) (GB)
Emerging Biopharmaceutical Enterprises (EBE)
France Biotech
Asebio (Spanish Bioindustry Association)
BIO Deutschland e. V.
European Bioeconomy Alliance (EBA)
» More Associations!
» Submit your Association!


 

Partners

» Media Partners
» Become a Partner


 


Advertisement


Organisation › DetailsHBM Healthcare Investments (Cayman) Ltd.http://www.hbmhealthcare.com
HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of some twenty five promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN). *
 




Start
2012-12-19 renamed before	 


 
Group
HBM (Group)



Industry
venture capital



Person
Wicki, Andreas (HBM Healthcare Investments 201402 CEO)


 
 
 


 
City
n. a. 


 
 
Address record changed: 2014-02-17


 
 
 


Basic data
Employees
n. a.   


 
 
 


 
 
* Document for �About Section�: Advanced Accelerator Applications S.A.. (2/17/14). "Press Release: Advanced Accelerator Applications Completes �41 Million Fund Raising". Saint-Genis-Pouilly.


 
 
 


 
 

	Record changed: 2017-04-01




Advertisement


More documents for HBM (Group)

[1] HBM Healthcare Investments Ltd.. (2/10/16). "Press Release: HBM Healthcare Investments Adds Cancer Immunotherapy Company Armo BioSciences to Portfolio [Not for distribution in the USA, Canada, Japan or Australia]". Zug....
[2] Allena Pharmaceuticals, Inc.. (12/9/15). "Press Release: Allena Pharmaceuticals Raises $53 Million in Series C Financing". Newton, MA....
[3] ObsEva S.A.. (11/23/15). "Press Release: ObsEva Closes CHF 60 (USD 60) Million in Series B Financing". Geneva....
[4] HBM Healthcare Investments Ltd.. (2/17/14). "Press Release: HBM Healthcare Investments Participates with EUR 20 Million in Financing Round of Advanced Accelerator Applications [Not for distribution in the USA, Canada, Japan or Australia]". Zug....
[5] Advanced Accelerator Applications S.A.. (2/17/14). "Press Release: Advanced Accelerator Applications Completes �41 Million Fund Raising". Saint-Genis-Pouilly....


 To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word �LSE newsletter�
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement



» top



Advertisements

















� Imprint  |  � Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2017. Made in Germany.










HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD. Form ADV Details as of 2016-11-08  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















WhaleWisdom /
Filer Search /
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD. /
Form ADV Filing



Quick Nav

Top
Identifying Info
SEC Registration
Organization
Advisory Business
Clients
Compensation
AUM
Advisory Activites
Other Business
Custody
Disclosures



Form ADV Compilation Report
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
Compilation done on 2016-11-08

Item 1 Identifying Information


A.


   Your full legal name (if you are a sole proprietor, your last, first, and middle names):





HBM, LLC




B.


   Name under which you primarily conduct your advisory business, if different from Item 1.A. 





HBM, LLC




D.


   your SEC file number:









E.


   If you have a number (“CRD Number”) assigned by the FINRA’s CRD system or by the IARD system, your CRD number





119322





    Principal Office and Place of Business
  




   33 EAST MAIN STREET, SUITE 400

      MADISON
      WI  53703
  






   Telephone number at this location:





608-257-0945







   Facsimile number at this location:





608-257-5764





      Mailing Address
    









I


   Do you have one or more websites?





  Yes
  No












M


   Are you registered with a foreign financial regulatory authority?





  Yes
  No





N


   Are you a public reporting company under Sections 12 or 15(d) of the Securities Exchange Act of 1934?





  Yes
  No





O


   Did you have $1 billion or more in assets on the last day of your most recent fiscal year?





  Yes
  No




Item 2 SEC Registration

To register (or remain registered) with the SEC, you must check at least one of the Items 2.A.(1) through
    2.A.(12), below. If you are submitting an annual updating amendment to your SEC registration and you
    are no longer eligible to register with the SEC, check Item 2.A.(13). Part 1A Instruction 2 provides
    information to help you determine whether you may affirmatively respond to each of these items.
    :
You (the adviser)


(1)




    are a large advisory firm
    




(2)




    are a mid-sized advisory firm
    




(3)




    have your principal office and place of business in Wyoming
    




(4)




    have your principal office and place of business outside the United States
    




(5)




    are an investment adviser (or sub-adviser) to an investment company registered under the Investment Company Act of 1940
    




(6)




    are an investment adviser to a company which has elected to be a business development
    company
    




(7)




    are a pension consultant with respect to assets of plans having an aggregate value of at least
    $200,000,000 that qualifies for the exemption in rule 203A-2(a)
    




(8)




    are a related adviser under rule 203A-2(b)
    




(9)




    ) are a newly formed adviser relying on rule 203A-2(c) because you expect to be eligible for SEC
    registration within 120 days;
    




(10)




    are a multi-state adviser that is required to register in 15 or more states and is relying on rule
    203A-2(d); 
    




(11)




    are an Internet adviser relying on rule 203A-2(e);
    




(12)




    have received an SEC order exempting you from the prohibition against registration with the
    SEC;
    




(13)




    are no longer eligible to remain registered with the SEC.
    


SEC Reporting by Exempt Reporting Advisors


(1)




    qualify for the exemption from registration as an adviser solely to one or more venture capital
    funds;
    




(2)




    qualify for the exemption from registration because you act solely as an adviser to private funds
    and have assets under management in the United States of less than $150 million;
    




(3)




    act solely as an adviser to private funds but you are no longer eligible to check box 2.B.(2)
    because you have assets under management in the United States of $150 million or more.
    


State Securities Authority Notice Filings and State Reporting by Exempt Reporing Advisors


C


   Under state laws, SEC-registered advisers may be required to provide to state securities authorities a copy
    of the Form ADV and any amendments they file with the SEC. These are called notice filings. In addition,
    exempt reporting advisers may be required to provide state securities authorities with a copy of reports and
    any amendments they file with the SEC. If this is an initial application or report, check the box(es) next to
    the state(s) that you would like to receive notice of this and all subsequent filings or reports you submit to
    the SEC. If this is an amendment to direct your notice filings or reports to additional state(s), check the
    box(es) next to the state(s) that you would like to receive notice of this and all subsequent filings or reports
    you submit to the SEC. If this is an amendment to your registration to stop your notice filings or reports
    from going to state(s) that currently receive them, uncheck the box(es) next to those state(s). 
















Item 3 Form of Organization


A


   How are you organized:





Limited Liability Company 




B


   In what month does your fiscal year end each year? 





DECEMBER




C


   Under the laws of what state or country are you organized?





WI  United States



Item 5 Information About Your Advisory Business


A


   Approximately how many employees do you have? Include full- and part-time employees but do not
     include any clerical workers.





0




B (1)


   Approximately how many of the employees reported in 5.A. perform investment advisory functions
    (including research)? 





0




(2)


   Approximately how many of the employees reported in 5.A. are registered representatives of a brokerdealer?





0




(3)


   Approximately how many of the employees reported in 5.A. are registered with one or more state
    securities authorities as investment adviser representatives? 





0




(4)


   Approximately how many of the employees reported in 5.A. are registered with one or more state
    securities authorities as investment adviser representatives for an investment adviser other than you? 





0




(5)


   Approximately how many of the employees reported in 5.A. are licensed agents of an insurance
    company or agency? 





0




(6)


   Approximately how many firms or other persons solicit advisory clients on your behalf? 





0



Clients


C (1)


   To approximately how many clients did you provide investment advisory services during your most
     recently completed fiscal year? 





0 




(2)


   Approximately what percentage of your clients are non-United States persons?





0




D (1)


   What types of clients do you have? Indicate the approximate percentage that each type of client
    comprises of your total number of clients. If a client fits into more than one category, check all
    that apply.









(a)


   Individuals (other than
    high net worth individuals) 





51-75 percent




(b)


   High net worth individuals





11-25 percent




(c)


   Banking or thrift institutions





0 percent




(d)


   Investment companies 





0 percent




(e)


   Business development companies





0 percent




(f)


   Pooled investment vehicles (other than
     investment companies)





0 percent




(g)


   Pension and profit sharing plans
     (but not the plan participants)





0 percent




(h)


   Charitable organizations 





0 percent




(i)


   Corporations or other businesses
     not listed above





Up to 10 percent




(j)


   State or municipal government entities





0 percent




(k)


   Other investment advisers





0 percent




(l)


   Insurance companies 





0 percent




(m)


   Other:





 




D (2)


   Indicate the approximate amount of your regulatory assets under management (reported in Item 5.F.
    below) attributable to each of the following type of client. If a client fits into more than one category,
    check all that apply









(a)


   Individuals (other than
        high net worth individuals) 





0 percent




(b)


   High net worth individuals





0 percent




(c)


   Banking or thrift institutions





0 percent




(d)


   Investment companies 





0 percent




(e)


   Business development companies





0 percent




(f)


   Pooled investment vehicles (other than
         investment companies)





0 percent




(g)


   Pension and profit sharing plans
         (but not the plan participants)





0 percent




(h)


   Charitable organizations 





0 percent




(i)


   Corporations or other businesses
         not listed above





0 percent




(j)


   State or municipal government entities





0 percent




(k)


   Other investment advisers





0 percent




(l)


   Insurance companies 





0 percent




(m)


   Other:





 



Compensation Arrangements


E


   You are compensated for your investment advisory services by (check all that apply): 









(1)




    A percentage of assets under your management
    




(2)




    Hourly charges
    




(3)




    Subscription fees (for a newsletter or periodical)
    




(4)




    Fixed fees (other than subscription fees) 
    




(5)




    Commissions 
    




(6)




    Performance-based fees
    




(7)




    Other
    



Regulatory Assets Under Management


F (1)


   Do you provide continuous and regular supervisory or management services to securities
     portfolios? 





  Yes
  No





F (2) (a)


   If yes, what is the amount of your regulatory assets under management?  Discretionary









F (2) (b)


   If yes, what is the amount of your regulatory assets under management?  Non-Discretionary









F (2) (c)


   If yes, what is the amount of your regulatory assets under management?  Total









F (2) (d)


   If yes, what is the total number of accounts?  Discretionary









F (2) (e)


   If yes, what is the total number of accounts?  Non-Discretionary









F (2) (f)


   If yes, what is the total number of accounts?  Total








Advisory Activities


G


   What type(s) of advisory services do you provide? Check all that apply. 









(1)




    Financial planning services 
    




(2)




    Portfolio management for individuals and/or small businesses 
    




(3)




    Portfolio management for investment companies (as well as “business development companies”
     that have made an election pursuant to section 54 of the Investment Company Act of 1940) 
    




(4)




    Portfolio management for pooled investment vehicles (other than investment companies) 
    




(5)




    Portfolio management for businesses (other than small businesses) or institutional clients
    (other than registered investment companies and other pooled investment vehicles) 
    




(6)




    Pension consulting services
    




(7)




    Selection of other advisers (including private fund managers)
    




(8)




    Publication of periodicals or newsletters 
    




(9)




    Security ratings or pricing services 
    




(10)




    Market timing services 
    




(11)




    Educational seminars/workshops
    




(12)




    Other
    




H


   If you provide financial planning services, to how many clients did you provide these services during your
    last fiscal year?





0







   If more than 500, how many?









I


   If you participate in a wrap fee program, do you (check all that apply): 









(1)




    sponsor the wrap fee program?
    




(2)




    act as a portfolio manager for the wrap fee program?
    




J


   In response to Item 4.B. of Part 2A of Form ADV, do you indicate that you provide investment advice only
    with respect to limited types of investments? 





  Yes
  No




Item 6 Other Business Activities


A


   You are actively engaged in business as a (check all that apply):









(1)




    broker-dealer (registered or unregistered)
    




(2)




    registered representative of a broker-dealer
    




(3)




    commodity pool operator or commodity trading advisor (whether registered or exempt from
    registration)
    




(4)




    futures commission merchant
    




(5)




    real estate broker, dealer, or agent 
    




(6)




    insurance broker or agent 
    




(7)




    bank (including a separately identifiable department or division of a bank) 
    




(8)




    trust company
    




(9)




    registered municipal advisor
    




(10)




    registered security-based swap dealer
    




(11)




    major security-based swap participant
    




(12)




    accountant or accounting firm 
    




(13)




    lawyer or law firm
    




(14)




    other financial product salesperson
    




B (1)


   Are you actively engaged in any other business not listed in Item 6.A. (other than giving investment
     advice)?





  Yes
  No





B (2)


   If yes, is this other business your primary business?





  Yes
  No





B (3)


   Do you sell products or provide services other than investment advice to your advisory clients?





  Yes
  No



Item 7 Financial Industry Affiliations and Private Fund Reporting


A


   This part of Item 7 requires you to provide information about you and your related persons, including
    foreign affiliates. Your related persons are all of your advisory affiliates and any person that is under
    common control with you.
    You have a related person that is a (check all that apply): 









(1)




    broker-dealer, municipal securities dealer, or government securities broker or dealer
    




(2)




    other investment adviser (including financial planners) 
    




(3)




    registered municipal advisor
    




(4)




    registered security-based swap dealer
    




(5)




    major security-based swap participant 
    




(6)




    commodity pool operator or commodity trading advisor (whether registered or exempt from
    registration) 
    




(7)




    futures commission merchant
    




(8)




    banking or thrift institution 
    




(9)




    trust company
    




(10)




    accountant or accounting firm
    




(11)




     lawyer or law firm 
    




(12)




    insurance company or agency
    




(13)




    pension consultant 
    




(14)




    real estate broker or dealer
    




(15)




    sponsor or syndicator of limited partnerships (or equivalent), excluding pooled
    investment vehicles 
    




(16)




    sponsor, general partner, managing member (or equivalent) of pooled investment vehicles
    




B.


   Are you an adviser to any private fund?





  Yes
  No



Item 8 Participation or Interest in Client Transactions


A. (1)


   Do you or any related person: buy securities for yourself from advisory clients, or sell securities you own to
     advisory clients (principal transactions)? 





  Yes
  No





(2)


   Do you or any related person: buy or sell for yourself securities (other than shares of mutual funds) that you
    also recommend to advisory clients?





  Yes
  No





(3)


   Do you or any related person: recommend securities (or other investment products) to advisory clients in
    which you or any related person has some other proprietary (ownership)
    interest (other than those mentioned in Items 8.A.(1) or (2))?





  Yes
  No





B. (1)


   Do you or any related person: as a broker-dealer or registered representative of a broker-dealer, execute
    securities trades for brokerage customers in which advisory client securities
    are sold to or bought from the brokerage customer (agency cross transactions)?





  Yes
  No





(2)


   Do you or any related person: recommend purchase of securities to advisory clients for which you or any related
        person serves as underwriter, general or managing partner, or purchaser representative?





  Yes
  No





(3)


   recommend purchase or sale of securities to advisory clients for which you or any
        related person has any other sales interest (other than the receipt of sales
        commissions as a broker or registered representative of a broker-dealer)?





  Yes
  No





C


   Do you or any related person have discretionary authority to determine the:









(1)


   securities to be bought or sold for a client’s account?





  Yes
  No





(2)


   amount of securities to be bought or sold for a client’s account?





  Yes
  No





(3)


   broker or dealer to be used for a purchase or sale of securities for a client’s account?





  Yes
  No





(4)


   commission rates to be paid to a broker or dealer for a client’s securities
    transactions?





  Yes
  No





D


   If you answer “yes” to C.(3) above, are any of the brokers or dealers related persons?





  Yes
  No





E


   Do you or any related person recommend brokers or dealers to clients?





  Yes
  No





F


   If you answer “yes” to E above, are any of the brokers or dealers related persons?





  Yes
  No





G (1)


   Do you or any related person receive research or other products or services
    other than execution from a broker-dealer or a third party (“soft dollar benefits”) in
    connection with client securities transactions?





  Yes
  No





(2)


   If "yes" to G.(1) above, are all the “soft dollar benefits” you or any
    related persons receive eligible “research or brokerage services” under section
    28(e) of the Securities Exchange Act of 1934?





  Yes
  No





H


   Do you or any related person, directly or indirectly, compensate any person for
    client referrals?





  Yes
  No





I


   Do you or any related person, directly or indirectly, receive compensation from any
    person for client referrals?





  Yes
  No




Item 9 Custody


A (1)


   Do you have custody of any advisory clients’ cash or bank accounts?:





  Yes
  No





(2)


   Do you have custody of any advisory clients’ securities?:





  Yes
  No





(2) (a)


   If you checked “yes” to Item 9.A.(1)(a) or (b), what is the approximate amount of client funds and securities for which you have custody:









(2) (b)


   If you checked “yes” to Item 9.A.(1)(a) or (b), what is the total number of clients for which you have custody::









B (1)


   In connection with advisory services you provide to clients, do any of your related persons have
    custody of any of your advisory clients’ cash or bank accounts?:





  Yes
  No





(2)


   In connection with advisory services you provide to clients, do any of your related persons have
        custody of any of your advisory clients’ securities?:





  Yes
  No





(2) (a)


   If you checked “yes” to Item 9.A.(1)(a) or (b), what is the approximate amount of client funds and securities for which your related persons have custody:









(2) (b)


   If you checked “yes” to Item 9.A.(1)(a) or (b), what is the total number of clients for which your related persons have custody::









C


   If you or your related persons have custody of client funds or securities in connection with advisory services you provide to clients, check all the following that apply:









(1)




    A qualified custodian(s) sends account statements at least quarterly to the investors in the pooled investment vehicle(s) you manage.
    




(2)




    An independent public accountant audits annually the pooled investment vehicle(s) that you manage and the audited financial statements are distributed to the investors in the pools.
    




(3)




    An independent public accountant conducts an annual surprise examination of client funds and securities.
    




(4)




    An independent public accountant prepares an internal control report with respect to custodial services when you or your related persons are qualified custodians for client funds and securities.
    




D


   Do you or your related person(s) act as qualified custodians for your clients in connection with advisory services you provide to clients?









(1)


   you act as a qualified custodian





  Yes
  No





(2)


   your related person(s) act as qualified custodian(s)





  Yes
  No





E


   If you are filing your annual updating amendment and you were subject to a surprise examination by an
    independent public accountant during your last fiscal year, provide the date (MM/YYYY) the examination commenced:









F


   If you or your related persons have custody of client funds or securities, how many persons, including,
     but not limited to, you and your related persons, act as qualified custodians for your clients in connection with advisory services you provide to clients?







Item 10 Control Persons


A


   Does any person not named in Item 1.A. or Schedules A, B, or C, directly or indirectly, control your management or policies?





  Yes
  No




Item 11 Disclosure Information





   Do any of the events below involve you or any of your supervised persons?





  Yes
  No





A. (1)


   In the past ten years, have you or any advisory affiliate: been convicted of or pled guilty or nolo contendere (“no contest”) in a
    domestic, foreign, or military court to any felony?





  Yes
  No





A. (2)


   In the past ten years, have you or any advisory affiliate: been charged with any felony?





  Yes
  No





B. (1)


   been convicted of or pled guilty or nolo contendere (“no contest”) in a domestic,
    foreign, or military court to a misdemeanor involving: investments or an
    investment-related business, or any fraud, false statements, or omissions,
    wrongful taking of property, bribery, perjury, forgery, counterfeiting, extortion,
    or a conspiracy to commit any of these offenses?





  Yes
  No





B. (2)


   been charged with a misdemeanor listed in Item 11.B.(1)?





  Yes
  No





C


   Has the SEC or the Commodity Futures Trading Commission (CFTC) ever:









 (1)


   found you or any advisory affiliate to have made a false statement or omission?





  Yes
  No





 (2)


   found you or any advisory affiliate to have been involved in a violation of SEC
    or CFTC regulations or statutes?





  Yes
  No





 (3)


   found you or any advisory affiliate to have been a cause of an investment-related
    business having its authorization to do business denied, suspended, revoked, or
    restricted?





  Yes
  No





 (4)


   entered an order against you or any advisory affiliate in connection with
    investment-related activity?





  Yes
  No





 (5)


   imposed a civil money penalty on you or any advisory affiliate, or ordered you
    or any advisory affiliate to cease and desist from any activity?





  Yes
  No





D


   Has any other federal regulatory agency, any state regulatory agency, or any foreign
    financial regulatory authority:









 (1)


   ever found you or any advisory affiliate to have made a false statement or
        omission, or been dishonest, unfair, or unethical?





  Yes
  No





 (2)


   ever found you or any advisory affiliate to have been involved in a violation of
        investment-related regulations or statutes?





  Yes
  No





 (3)


   ever found you or any advisory affiliate to have been a cause of an investment-
        related business having its authorization to do business denied, suspended,
        revoked, or restricted?





  Yes
  No





 (4)


   in the past ten years, entered an order against you or any advisory affiliate in
        connection with an investment-related activity?





  Yes
  No





 (5)


   ever denied, suspended, or revoked your or any advisory affiliate’s registration or
        license, or otherwise prevented you or any advisory affiliate, by order,
        from associating with an investment-related business or restricted your or any
        advisory affiliate’s activity?





  Yes
  No





E


   Has any self-regulatory organization or commodities exchange ever:









 (1)


   found you or any advisory affiliate to have made a false statement or omission?





  Yes
  No





 (2)


   found you or any advisory affiliate to have been involved in a violation of its
         rules (other than a violation designated as a “minor rule violation” under a plan
         approved by the SEC)?





  Yes
  No





 (3)


   found you or any advisory affiliate to have been the cause of an investment-
         related business having its authorization to do business denied, suspended,
         revoked, or restricted?





  Yes
  No





 (4)


   disciplined you or any advisory affiliate by expelling or suspending
         you or the advisory affiliate from membership, barring or suspending you or
         the advisory affiliate from association with other members, or otherwise
         restricting your or the advisory affiliate’s activities?





  Yes
  No





F


   Has an authorization to act as an attorney, accountant, or federal contractor granted
    to you or any advisory affiliate ever been revoked or suspended?





  Yes
  No





G


   Are you or any advisory affiliate now the subject of any regulatory proceeding that
    could result in a “yes” answer to any part of Item 11.C., 11.D., or 11.E.?





  Yes
  No





H (1)


   Has any domestic or foreign court:









 (a)


   in the past ten years, enjoined you or any advisory affiliate in connection with any
             investment-related activity?





  Yes
  No





 (b)


   ever found that you or any advisory affiliate were involved in a violation of
             investment-related statutes or regulations?





  Yes
  No





 (c)


   ever dismissed, pursuant to a settlement agreement, an investment-related
             civil action brought against you or any advisory affiliate by a state or foreign
             financial regulatory authority?





  Yes
  No





 (2)


   Are you or any advisory affiliate now the subject of any civil proceeding that could
    result in a “yes” answer to any part of Item 11.H(1)?





  Yes
  No











Elevate your investments
Try it for free
















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft









 







Insights | PGIM


















Insights
www.pgim.com


en


8CfbchSFCL_szZ6lgYB8WDJ

Asset Management

Skip to main content














 News


 Careers


 Contact












Menu



Close






PGIM Home







 Home


 About Us


 Overview


 Partnering with PGIM


 Leadership


 Strengths


 Company Values


 History


 Locations




 Our Businesses


 Overview


 PGIM Fixed Income


 PGIM Real Estate


 Jennison Associates


 QMA


 Pricoa Capital Group


 PGIM Real Estate Finance


 International Investments


 PGIM Funds




Insights
 Insights


 Overview


 Megatrends


 Current Views


 Asset Class Insights








Close












{}






Z7_K8HEHHG0LOCHF0ABFJMQE5RDN4







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 
































EMERGING MARKETS AT THE CROSSROADS


A radical shift in the forces shaping emerging market growth will require investors to take a different investment approach from what may have worked in the past.

 Read more about the new emerging markets landscapeRead more about the new emerging markets landscape














 


For latest news and content, 
			follow @PGIM on Twitter.





 













Z7_K8HEHHG0LOCHF0ABFJMQE5RTP5







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 




































Megatrends
Long-term views on the investment implications of megatrends.
 Learn more about megatrends
























Current Views
Views addressing today’s institutional investor concerns.
 Read our current views
























Asset Class Insights
Expert insights from our asset class specialists.
 View insights by asset class























 

Z7_K8HEHHG0L0N540ABFSHGHT3V70







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 




































MEGATRENDS
We see alpha in today’s global megatrends. At PGIM, we help clients see the investable implications of today’s most important economic and societal trends – the megatrends that we believe will reshape the U.S. and the world, driving long-term value. PGIM provides a broader lens through which to view those opportunities, across a broad range of asset classes and countries, to capture real investment alpha. Unprecedented urban expansion and global longevity are two of those trends.






























Urban Expansion






























Rising Longevity























 

Z7_K8HEHHG0LOCHF0ABFJMQE5RNT1







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 

























					
					
						CURRENT VIEWS
					
				




 


























Value of Active
Read more about the value of active management






























Markets & Economy
Read our commentary on the markets & economy






























Asset Allocation
Read our insights on asset allocation strategies























 

Z7_K8HEHHG0LOCHF0ABFJMQE5R775







Web Content Viewer



Component Action Menu





${title}


 
${loading}













Actions



 






































ASSET CLASS INSIGHTS
PGIM’s independent investment businesses specialize by asset class and approach. Read institutional thought leadership by strategy, from capital market experts.



















































 



 





Back to top



















 